Home - News
Certainly, there is news. Tapadar Pharma Compliance was joined by yet
a further dedicated employee.
We warmly welcome
Ms Ruth Wassmer as Head Administration and Professional Support
to our team.
Furthermore, for the active substance Nitisonine, Tapadar Pharma Compliance
obtained the Orphan Drug status from Swissmedic. Currently, a marketing
authorisation for Switzerland is pursued.
"It is more important being able to count on your employees than counting them."